The Role of Natriuretic Peptides in Management of Premature Infants with Hemodynamically Significant Patent Arterial Duct

The Role of Natriuretic Peptides in Management of Premature Infants with Hemodynamically Significant Patent Arterial Duct

Hemodynamically significant patent arterial duct in premature infants can be the reason of life-threatening complications. Thus it is topical to define the high risk of such complications and mortality in early neonatal period. We have reviewed researches results covering prognostic value of natriur...

Full description

Bibliographic Details
Main Authors:	Evgenij G. Furman, Aleksej N. Biyanov, Artem Porodikov, Oksana B. Bahmet’eva, Vladimir G. Druzhen’kov
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2019-04-01
Series:	Вопросы современной педиатрии
Subjects:	гемодинамически значимый функционирующий артериальный проток недоношенные дети натрийуретические пептиды прогноз риск осложнения смерть
Online Access:	https://vsp.spr-journal.ru/jour/article/view/2021

Similar Items

Фонокардиография и открытый артериальный проток у недоношенных новорожденных детей
by: V.A. Shelevytska, et al.
Published: (2020-03-01)

CANDIDATE LABORATORY MARKERS OF LONG-TERM FUNCTIONING OF THE DUCTUS ARTERIOSUS IN EXTREMELY LOW BIRTH WEIGHT INFANTS
by: Мария Вячеславовна Пересторонина, et al.
Published: (2022-03-01)

THE PARAMETERS OF THE OXYGEN STATUS IN THE ASSESSMENT OF PROGNOSIS OF A HEMODYNAMICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS PRETERM NEONATAL INFANTS
by: M. V. Perestoronina, et al.
Published: (2015-05-01)

FEATURES OF EARLY POSTNATAL ADAPTATION IN PREMATURE INFANTS WITH EXTREMELY LOW AND VERY LOW BODY WEIGHT IN THE PRESENCE OF A FUNCTIONING PATENT DUCTUS ARTERIOSUS AT BIRTH
by: Жанна Анатольевна Звягина, et al.
Published: (2023-02-01)

Случай хирургической коррекции инфекционного эндокардита аортального клапана при функционирующем открытом артериальном протоке у взрослого
by: S. I. Andrievskikh, et al.
Published: (2017-07-01)

Clinical and morphological features of arterial duct in premature newborns
by: O. P. Saryyeva, et al.
Published: (2022-11-01)

OPEN ARTERIAL DUCT IN PREMATURE NEWBORN: TACTICS OF NEONATOLOGIST
by: D. S. Kryuchko, et al.
Published: (2011-01-01)

Specific features of the clinical manifestations of patent ductus arteriosus in extremely premature newborns
by: E. M. Spivak, et al.
Published: (2016-02-01)

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)

THE MODERN VIEW ON PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTS
by: Жанна Анатольевна Звягина, et al.
Published: (2018-12-01)

Natriuretic peptides and chronic heart failure in arterial hypertension patients
by: Yu. A. Vasuyk, et al.
Published: (2007-04-01)

A clinical importance of natriuretic peptides in pediatric practice
by: Е. В. Саперова, et al.
Published: (2017-04-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

PATENT DUCTUS ARTERIOSUS - GOOD AND EVIL IN ONE VESSEL
by: E L Bokerya, et al.
Published: (2017-12-01)

Natriuretic peptides: new challenges — new solutions
by: O. M. Drapkina, et al.
Published: (2021-11-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

СОВРЕМЕННЫЙ ВЗГЛЯД НА КЛАССИФИКАЦИЮ И ДИАГНОСТИКУ ОТКРЫТОГО АРТЕРИАЛЬНОГО ПРОТОКА (ОБЗОР)
by: Л.Ю. Артюх, et al.
Published: (2023-09-01)

Стентирование перешейка аорты в качестве метода коррекции коарктационного синдрома, вызванного окклюдером открытого артериального протока: клинический случай
by: R.S. Tarasov, et al.
Published: (2022-12-01)

CLINICAL SIGNIFICANCE OF DETERMINING THE LEVEL OF THE BRAIN NATRIURETIC PEPTIDE FOR THE DIAGNOSIS OF HEART FAILURE OF COMORBID PATIENTS WITH CORONARY HEART DISEASE AND THYROTOXICOSIS
by: E. V. Pashchenko, et al.
Published: (2017-09-01)

Perioperative Myocardial Damage and Heart Failure in Noncardiac Surgery. Part 1. Etiopathogenesis and Prognosis of Perioperative Cardiac Complications (Review)
by: I. A. Kozlov, et al.
Published: (2019-04-01)

ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ СУБСТРАТОВ СИСТЕМЫ НАТРИЙУРЕТИЧЕСКИХ ПЕПТИДОВ В ОЦЕНКЕ РИСКА РАЗВИТИЯ ЖЕЛУДОЧКОВЫХ АРИТМИЙ У ПАЦИЕНТОВ С СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ И ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ
by: M. Ch. Matsiukevich, et al.
Published: (2022-07-01)

The Perioperative Changes in and Clinical Value of B-type Natriuretic Peptide Levels in the Blood of Cardiosurgical Patients
by: I. A. Kozlov, et al.
Published: (2012-08-01)

СВЯЗЬ ПОЛИМОРФНОГО ВАРИАНТА RS989692 ГЕНА НЕПРИЛИЗИНА (MME) С УРОВНЕМ НАТРИЙУРЕТИЧЕСКИХ ПЕПТИДОВ И ЕГО КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ У ПАЦИЕНТОВ С СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ И ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ
by: М. Ч. Матюкевич, et al.
Published: (2023-05-01)

Increased B-type Natriuretic Peptide (NT-proBNP) Level as a Risk Factor in Cardiosurgical Patients
by: I. A. Kozlov, et al.
Published: (2010-02-01)

Natriuretic peptide family. Options for use in outpatient practice
by: S. V. Ivanova, et al.
Published: (2014-12-01)

Tissue myocardial Doppler echocardiography in the assessment of right ventricular function among patients with pulmonary hypertension of various aetiology
by: Yu. A. Andreeva, et al.
Published: (2010-04-01)

Reduction of risk of perioperative complications in case of cardiac comorbidity
by: I. A. Kozlov, et al.
Published: (2020-05-01)

Septic cardiopathy: disputable issues and prospects
by: I. A. Kozlov, et al.
Published: (2020-05-01)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)

Electroencephalogram in premature infants: from normal to pathological activity
by: D. A. Chegodaev, et al.
Published: (2019-05-01)

Principal factors affecting sudden death risk in myocardial infarction patients
by: S. A. Boldueva, et al.
Published: (1970-01-01)

LOGIC OF BUILDING THE AIRCRAFT MAINTENANCE SYSTEM BASED ON EXPERIENCE OF MSG-3
by: I. V. Spichenko
Published: (2016-11-01)

Возможности предоперационной оценки риска неблагоприятного исхода абдоминальных операций: предварительные результаты многоцентрового исследования STOPRISK
by: Игорь Борисович Заболотских, et al.
Published: (2020-11-01)

Vascular complications after orthotopic liver transplantation
by: M. S. Novruzbekov, et al.
Published: (2017-03-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020)
by: S. N. Tereshchenko, et al.
Published: (2020-09-01)

Clinical and psychological factors affecting sudden death risk in myocardial infarction patients
by: S. A. Boldueva, et al.
Published: (1970-01-01)

JUSTIFICATION OF A SYSTEMIC APPROACH IN THE SUDDEN CARDIAC DEATH PREVENTION: A POSSIBLE SOLUTION TO THE PROBLEM OF EXCESSIVE MORTALITY IN RUSSIA (LITERATURE REVIEW) PART I. CARDIOVASCULAR ASPECTS OF EXCESSIVE MORALITY IN RUSSIA: THE STATE OF THE PROBLEM AND POTENTIAL FOR PREVENTION
by: A. S. Dimov, et al.
Published: (2013-04-01)

Forecast successful prevention of infectious complications in preterm infants
by: N. V. Gonchar, et al.
Published: (2016-04-01)

HAVE WE SHIFTED OUR PARADIGM OF CLOPIDOGREL AS A MANDATORY DRUG IN TREATMENT OF CARDIOLOGICAL PATIENTS AFTER THE INTRODUCTION OF MORE POWERFUL ANTIAGREGANTS?
by: E. P. PANCHENKO
Published: (2017-12-01)

CLINICAL VALUE OF BLOOD BIOMARKERS IN PATIENTS WITH CHRONIC HEART FAILURE
by: A. M. Aliyeva, et al.
Published: (2018-10-01)